Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.16 USD | +1.28% | +5.90% | -12.37% |
Mar. 18 | Chemours Notified of Non-Compliance With NYSE's Listing Standards | MT |
Mar. 08 | News Highlights : Top Company News of the Day - Thursday at 11 PM ET | DJ |
Financials (USD)
Sales 2023 * | 6B | Sales 2024 * | 6.18B | Capitalization | 4.13B |
---|---|---|---|---|---|
Net income 2023 * | -173M | Net income 2024 * | 470M | EV / Sales 2023 * | 1.14 x |
Net Debt 2023 * | 2.74B | Net Debt 2024 * | 3B | EV / Sales 2024 * | 1.15 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
7.94
x | Employees | 6,600 |
Yield 2023 * |
3.58% | Yield 2024 * |
3.69% | Free-Float | 74.59% |
Latest transcript on The Chemours Company
1 day | +2.43% | ||
1 week | +6.43% | ||
Current month | +41.33% | ||
1 month | -1.14% | ||
3 months | -9.77% | ||
6 months | -11.86% | ||
Current year | -11.86% |
Managers | Title | Age | Since |
---|---|---|---|
Denise Dignam
CEO | Chief Executive Officer | 58 | 14-12-31 |
Matthew Abbott
DFI | Director of Finance/CFO | 48 | 16-12-31 |
Brandon Ontjes
IRC | Investor Relations Contact | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Cranston
BRD | Director/Board Member | 76 | 15-06-18 |
Curtis Anastasio
BRD | Director/Board Member | 67 | 15-06-18 |
Sean Keohane
BRD | Director/Board Member | 56 | 17-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.46% | 3,414 M€ | +7.62% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-19 | 27.64 | -0.58% | 8 666 |
24-03-18 | 27.8 | +2.43% | 1,818,416 |
24-03-15 | 27.14 | +1.84% | 2,936,480 |
24-03-14 | 26.65 | -0.71% | 1,366,968 |
24-03-13 | 26.84 | +2.84% | 1,434,412 |
Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.86% | 4.13B | |
+13.13% | 88.8B | |
+0.46% | 47.55B | |
-4.43% | 30.7B | |
+6.66% | 17.94B | |
-6.01% | 12.29B | |
+2.76% | 10.83B | |
+7.75% | 10.4B | |
-13.86% | 9.29B | |
-2.32% | 8.83B |